
### [MONDO:0020154](http://purl.obolibrary.org/obo/MONDO_0020154)
**Label:** Microblepharon-ablephara syndrome

**Subclasses:** [MONDO:0008693](http://purl.obolibrary.org/obo/MONDO_0008693) (ablepharon macrostomia syndrome), [MONDO:0008853](http://purl.obolibrary.org/obo/MONDO_0008853) (Barber-Say syndrome), 

**Mapped go classes:** [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0045668](http://purl.obolibrary.org/obo/GO_0045668) (negative regulation of osteoblast differentiation), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0010838](http://purl.obolibrary.org/obo/GO_0010838) (positive regulation of keratinocyte proliferation), [GO:0043392](http://purl.obolibrary.org/obo/GO_0043392) (negative regulation of DNA binding), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001076](http://purl.obolibrary.org/obo/GO_0001076) (transcription factor activity, RNA polymerase II transcription factor binding), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation), [GO:0032720](http://purl.obolibrary.org/obo/GO_0032720) (negative regulation of tumor necrosis factor production), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0045638](http://purl.obolibrary.org/obo/GO_0045638) (negative regulation of myeloid cell differentiation), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0061303](http://purl.obolibrary.org/obo/GO_0061303) (cornea development in camera-type eye), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0044092](http://purl.obolibrary.org/obo/GO_0044092) (negative regulation of molecular function), 

**Class expressions from DL-Learner:**

- [GO:1903556](http://purl.obolibrary.org/obo/GO_1903556) (negative regulation of tumor necrosis factor superfamily cytokine production) 57.14%
- [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis) 57.14%
- [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis) 57.14%
- [GO:0048704](http://purl.obolibrary.org/obo/GO_0048704) (embryonic skeletal system morphogenesis) 57.14%
- [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis) 57.14%
- [GO:0045668](http://purl.obolibrary.org/obo/GO_0045668) (negative regulation of osteoblast differentiation) 57.14%
- [GO:0032720](http://purl.obolibrary.org/obo/GO_0032720) (negative regulation of tumor necrosis factor production) 57.14%
- [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation) 57.14%
- [GO:0045667](http://purl.obolibrary.org/obo/GO_0045667) (regulation of osteoblast differentiation) and [GO:0051093](http://purl.obolibrary.org/obo/GO_0051093) (negative regulation of developmental process) 57.14%
- [GO:0045667](http://purl.obolibrary.org/obo/GO_0045667) (regulation of osteoblast differentiation) and [GO:0048523](http://purl.obolibrary.org/obo/GO_0048523) (negative regulation of cellular process) 57.14%
- [GO:0045667](http://purl.obolibrary.org/obo/GO_0045667) (regulation of osteoblast differentiation) and [GO:0048519](http://purl.obolibrary.org/obo/GO_0048519) (negative regulation of biological process) 57.14%
- [GO:0045596](http://purl.obolibrary.org/obo/GO_0045596) (negative regulation of cell differentiation) and [GO:0045667](http://purl.obolibrary.org/obo/GO_0045667) (regulation of osteoblast differentiation) 57.14%
- [GO:0032680](http://purl.obolibrary.org/obo/GO_0032680) (regulation of tumor necrosis factor production) and [GO:1903556](http://purl.obolibrary.org/obo/GO_1903556) (negative regulation of tumor necrosis factor superfamily cytokine production) 57.14%
- [GO:0032680](http://purl.obolibrary.org/obo/GO_0032680) (regulation of tumor necrosis factor production) and [GO:0051241](http://purl.obolibrary.org/obo/GO_0051241) (negative regulation of multicellular organismal process) 57.14%
- [GO:0032680](http://purl.obolibrary.org/obo/GO_0032680) (regulation of tumor necrosis factor production) and [GO:0048519](http://purl.obolibrary.org/obo/GO_0048519) (negative regulation of biological process) 57.14%


